Nasal Packing DurationNCT07775118
Comparative Study of Nasal Packing Duration: One-Day Packing Versus Three-Day Packing After Turbinate Surgery
A study testing Nasal packing for 1 day and Nasal packing for 3 days in people with Nasal Packing Duration and One-Day Packing, run by Tanta University at 1 site in Egypt.
Trial summary
This study aimed to assess the optimum timing for nasal packs removal after turbinate surgery by comparing removal after one day versus removal after three days. Read more about this study
- Who is it for?
- Ages 18 to 45 years
- Conditions the study is for
- Nasal Packing Duration, One-Day Packing, Three-Day Packing
- What is being tested?
- Nasal packing for 1 day and Nasal packing for 3 days
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 66 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2025to 1 Jan 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Aged from 18 years to 45 years old.
- Both sexes.
- Patients with inferior turbinate hypertrophy.
- Following unsatisfactory medical treatment for at least three months.
Who cannot join
- Medically unfit patients (hypertensive and diabetic patients).
- Patients with bleeding tendencies.
- patients with Severe deviated septum.
- Congenital anomalies.
Trial locations and contacts
1 site in 1 country.
About this study
This study aimed to assess the optimum timing for nasal packs removal after turbinate surgery by comparing removal after one day versus removal after three days.
Read the detailed description
Nasal obstruction is a common symptom that reaches 25% of the population worldwide. The main etiologies for nasal obstruction are septal deviation, hypertrophy of the inferior and middle turbinates, and nasal polyposis.
Hypertrophied inferior turbinate surgery techniques include Cauterization, Radiofrequency turbinate reduction, Coblation, Submucosal diathermy, Microdebrider and submucosal resection.
Endoscopic Partial inferior turbinectomy addresses both the hypertrophic mucosa and the underlying bone while leaving a normal-sized turbinate behind.
- Being tested
- Nasal packing for 1 day, Nasal packing for 3 days
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Nasal packing for 1 dayProcedure or surgery
Patients were scheduled for nasal packing for 1 day
Nasal packing for 3 daysProcedure or surgery
Patients were scheduled for nasal packing for 3 days
| Study group | Role | What they receive |
|---|---|---|
| Group (A) | Experimental | Patients were scheduled for nasal packing for 1 day Receives: Procedure: Nasal packing for 1 day |
| Group (B) | Experimental | Patients were scheduled for nasal packing for 3 days Receives: Procedure: Nasal packing for 3 days |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative bleeding
Incidence of postoperative bleeding was recorded.
Measured: Six months after surgery
Secondary outcomes (3)
Improvement in nasal obstruction
Improvement in nasal obstruction was assessed using the legalized Arabic version of the Nasal Obstruction Symptom Evaluation (Arabic NOSE) scale. The Arabic NOSE scale consists of five items scored on a five-point Likert scale, with total scores extending from 0 to 100; developed scores indicate more severe nasal obstruction.
Measured: Six months after surgery
Bleeding during nasal pack removal
Incidence of bleeding during nasal pack removal was recorded.
Measured: Intraoperatively
Postoperative pain
Postoperative pain was judged utilizing the Visual Analogue Scale (VAS). VAS is a straight 10-centimeter line where 0 means no pain and 10 means the worst pain.
Measured: Six months after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Aug 2026
- Study start1 Jan 2025
- Primary completion1 Jan 2026
- Study completion1 Jan 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Nasal Packing DurationStudies of the same condition, open and under way.
- More trials run by Tanta UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 66 participants (actual)
Sponsor and investigators
- Lead sponsor
- Tanta University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Amin Khaled Amin ELBatawy, Tanta University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07775118
- Sponsor's protocol ID
- 36264MS764/12/24
- Status last verified
- Aug 2026
- First submitted
- 15 Aug 2026
- Last updated
- 20 Aug 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Study at a glance
From the registry record, last updated by the sponsor on 20 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Study of Nasal Packing Duration: One-Day Packing Versus Three-Day Packing After Turbinate Surgery
- ClinicalTrials.gov ID
- NCT07775118
- Acronym / sponsor ID
- 36264MS764/12/24
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 66 participants (actual)
- Lead sponsor
- Tanta UniversityUniversity, hospital or other
- Study start
- 1 Jan 2025 (actual)
- Primary completion
- 1 Jan 2026 (actual)
- Study completion
- 1 Jan 2026 (actual)
- First posted
- 20 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aimed to assess the optimum timing for nasal packs removal after turbinate surgery by comparing removal after one day versus removal after three days.
Detailed description
Nasal obstruction is a common symptom that reaches 25% of the population worldwide. The main etiologies for nasal obstruction are septal deviation, hypertrophy of the inferior and middle turbinates, and nasal polyposis.
Hypertrophied inferior turbinate surgery techniques include Cauterization, Radiofrequency turbinate reduction, Coblation, Submucosal diathermy, Microdebrider and submucosal resection.
Endoscopic Partial inferior turbinectomy addresses both the hypertrophic mucosa and the underlying bone while leaving a normal-sized turbinate behind.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group (A) | Experimental | Procedure: Nasal packing for 1 dayPatients were scheduled for nasal packing for 1 day |
| Group (B) | Experimental | Procedure: Nasal packing for 3 daysPatients were scheduled for nasal packing for 3 days |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Aged from 18 years to 45 years old.
- Both sexes.
- Patients with inferior turbinate hypertrophy.
- Following unsatisfactory medical treatment for at least three months.
Key exclusion criteria (4 listed)
- Medically unfit patients (hypertensive and diabetic patients).
- Patients with bleeding tendencies.
- patients with Severe deviated septum.
- Congenital anomalies.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Nasal packing for 1 dayPatients were scheduled for nasal packing for 1 day | Procedure or surgery | Group (A) |
| Nasal packing for 3 daysPatients were scheduled for nasal packing for 3 days | Procedure or surgery | Group (B) |
Primary outcome
Postoperative bleeding
Time frame: Six months after surgery
Incidence of postoperative bleeding was recorded.
3 secondary outcomes
Improvement in nasal obstruction
Time frame: Six months after surgery
Bleeding during nasal pack removal
Time frame: Intraoperatively
Postoperative pain
Time frame: Six months after surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Aug 2026.
- Individual participant dataSharing planned: Yes. The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Related trials for Nasal Packing Duration
RecruitingObservational study
Nasal Packing Duration and Development of Pharyngitis After Septorhinoplasty Surgery
Rhinitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Nasal packing for 1 day and Nasal packing for 3 days in people with Nasal Packing Duration and One-Day Packing, run by Tanta University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative bleeding (time frame: Six months after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.